Kate Lorig1, Philip L Ritter1, Marcia G Ory2, Nancy Whitelaw3. 1. Stanford Patient Education Research Center, Stanford, CA, USA (Dr Lorig, Dr Ritter) 2. Texas A&M Health Science Center, College Station, TX, USA (Dr Ory) 3. National Council on Aging, Washington, DC, USA (Dr Whitelaw)
Abstract
PURPOSE: The purpose of the study was to determine the feasibility and efficacy of a generic chronic disease self-management program for people with type 2 diabetes. METHODS: English-speaking adults with type 2 diabetes who were part of a larger US national translation study of the Stanford Chronic Disease Self-Management Program (CDSMP) were invited to be part of the current study. In addition to completing self-report questionnaires, participants submitted blood samples at baseline, 6 months, and 12 months. Of the 114 participants, half had A1C values between 6% and 6.9% and half had values of 7.0% or more. RESULTS: Adults with diabetes successfully participated in CDSMP workshops in a community health setting. Participants demonstrated statistically significant improvements in health indicators and behaviors but no reductions in health care utilization. Participants with A1C of 7% and above had A1C reductions at 6 months, with smaller reductions at 12 months. Those with baseline A1C less than 7% had no changes in A1C at 6 or 12 months. CONCLUSIONS: The results suggest that the CDSMP is a useful and appropriate program for lowering A1C among those with A1C above 7% and for improving health status for people with diabetes, regardless of their A1C.
PURPOSE: The purpose of the study was to determine the feasibility and efficacy of a generic chronic disease self-management program for people with type 2 diabetes. METHODS: English-speaking adults with type 2 diabetes who were part of a larger US national translation study of the Stanford Chronic Disease Self-Management Program (CDSMP) were invited to be part of the current study. In addition to completing self-report questionnaires, participants submitted blood samples at baseline, 6 months, and 12 months. Of the 114 participants, half had A1C values between 6% and 6.9% and half had values of 7.0% or more. RESULTS: Adults with diabetes successfully participated in CDSMP workshops in a community health setting. Participants demonstrated statistically significant improvements in health indicators and behaviors but no reductions in health care utilization. Participants with A1C of 7% and above had A1C reductions at 6 months, with smaller reductions at 12 months. Those with baseline A1C less than 7% had no changes in A1C at 6 or 12 months. CONCLUSIONS: The results suggest that the CDSMP is a useful and appropriate program for lowering A1C among those with A1C above 7% and for improving health status for people with diabetes, regardless of their A1C.
Authors: Jared W Magnani; Danielle Ferry; Gretchen Swabe; Deborah Martin; Xirun Chen; Maria M Brooks; Samar R El Khoudary Journal: Am Heart J Plus Date: 2021-03
Authors: Suzanne Held; John Hallett; Mark Schure; Alma Knows His Gun McCormick; Sarah Allen; Shauna Milne-Price; Coleen Trottier; Brianna Bull Shows; Lucille Other Medicine; Jillian Inouye Journal: Soc Sci Med Date: 2019-10-03 Impact factor: 4.634
Authors: Meng-Chien Tsai; Hsiao-Ling Chuang; Cheng-Yi Huang; Shu-Hsin Lee; Wen-Chun Liao; Meng-Chih Lee; Ching-Pyng Kuo Journal: Int J Environ Res Public Health Date: 2021-07-05 Impact factor: 3.390
Authors: Philip Lloyd Ritter; Marcia G Ory; Matthew Lee Smith; Luohua Jiang; Audrey Alonis; Diana D Laurent; Kate Lorig Journal: Front Public Health Date: 2015-04-27
Authors: Stacey E Jolly; Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Victoria Konig; Yvette K Burrucker; Jennifer Hyland; Priscilla Dann; Barbara H Tucky; John W Sharp; Joseph V Nally Journal: BMC Nephrol Date: 2015-05-03 Impact factor: 2.388